REPATHA® NOW INDICATED FOR ADULTS AT INCREASED RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS DUE TO UNCONTROLLED LDL-C AmgenAmgen says FDA broadens the approved use of Repatha TipRanksFDA expands Repatha approval for adults with high LDL cholesterol Investing.comMajor FDA Win: Amgen’s Repatha Now Available to Millions More At-Risk Heart Patients Without CV Disease Stock Titan
